|
See related Fosrenol chewable tab information |
|
|
|
Manufacturer |
Fresenius Kabi |
|
Distributor |
DKSH |
|
Contents |
Lanthanum carbonate |
|
Indications |
Phosphate binding agent to control hyperphosphatemia in chronic renal failure patients on hemodialysis or continuous ambulatory peritoneal dialysis.
Click to view Fosrenol detailed prescribing infomation |
|
Dosage |
Adult & elderly (>65 yr) 750-2,250 mg/day. Max duration: 3 yr.
Click to view Fosrenol detailed prescribing infomation |
|
Overdosage |
View Fosrenol overdosage for action to be taken in the event of an overdose. |
|
Administration |
Should be taken with food (Take w/ or immediately after food, w/ the daily dose divided between meals. Chew thoroughly before swallowing. Do not swallow whole.). |
|
Contraindications |
Hypophosphatemia.
Click to view Fosrenol detailed prescribing infomation |
|
Special Precautions |
Acute peptic ulcer, ulcerative colitis, Crohn's disease or bowel obstruction. Monitor serum Ca levels in patients w/ renal insufficiency. Severe hepatic impairment. Pregnancy & lactation. Childn <18 yr.
Click to view Fosrenol detailed prescribing infomation |
|
Adverse Drug Reactions |
GI reactions eg abdominal pain, constipation, diarrhea, dyspepsia, flatulence, nausea & vomiting. Hypocalcemia.
View ADR Monitoring Form |
|
Drug Interactions |
Chloroquine, hydroxychloroquine & ketoconazole. Tetracycline, doxycycline & floxacins.
View more drug interactions with Fosrenol |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Caution For Usage |
For caution against possible variation of physical aspect of medicine... click to view Fosrenol detailed prescribing infomation |
|
Storage |
View Fosrenol storage conditions for details to ensure optimal shelf-life. |
|
Description |
View Fosrenol description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Fosrenol mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
